November 2, 2023 | Issue #75

Hey there! We've talked about cold plunge, but what about cryotherapy? Is it legit or just another fad with little benefit? You decide...  

In this week's newsletter:🥶 Colder Than Cold 💰 Miromatrix Gets Acquired🌐 Cold Plunges Going Mainstream    

Cryotherapy: Freeze Your Way to Health, and Increase Your Longevity?

In the US, cryotherapy is not FDA approved. That's because, according to their standards, the scientific evidence supporting cryotherapy is scanty.However, did you know that some countries not only approve cryotherapy, but also cover the costs for individuals through their national health care system!As you'll find out in today's article, there are many, many benefits to cryotherapy. Still, most western medicine authorities haven't bought into the positive benefits that cryotherapy provides. That hasn't stopped many longevity and health seekers from paying out of pocket in pursuit of this exotic cold therapy. In fact, cryotherapy usage is projected to grow 7% per year for the next decade!Learn all about cryotherapy and let us know if you've tried it before... 

Confirmed speakers for the Longevity Summit 2023 include:

• George Church, PhD: Professor, Harvard University

• Kristen Fortney, PhD: CEO & Co-founder, BioAge Labs

• Steve Horvath, PhD: Principal Investigator, Altos Labs

• Nikolina Lauc: CEO, GlycanAge

• Eric Verdin, MD: CEO/President, Buck Institute

• Daisy Robinton, PhD: CEO & Co-founder, Oviva Therapeutics

• Spring Behrouz, PhD: Co-Founder & CEO, Vincere Bio

• Omri Amirov-Drory, PhD: CEO & Co-founder, Renewal Bio

• Many more... 

Click here and use code "Spannr23" at checkout for 15% off

• The National Institute on Aging is hiring a Senior Program Manager APPLY HERE.

• Browse thousands of jobs in the longevity industry, updated daily, in Spannr's new Jobs database HERE. 

• United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced a definitive agreement for United Therapeutics to acquire Miromatrix for $91M. Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that includes four ongoing registration-phase studies. The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D bioprinting, and regenerative medicine approaches with the objective of creating an unlimited supply of tolerable, transplantable organs.

• Explore Spannr's Longevity Investor database HERE.

• Cold plunges are going corporate (The Hustle)

• Lessons on living to 100: Four "blue zone" strategies that can be applied anywhere (Salon)

• Morbid ‘longevity’ test reveals at what age you’ll die — but is it legit? (NY Post)

• Walking 9,000 steps a day linked to extended lifespan, pace also plays huge role: Study (WION)

• Gene transfer leads to longer life and healthspan (Big Think)

• Blocking ‘Jumping Genes’ Could Drastically Increase Our Lifespan, New Research Shows (Popular Mechanics)

• Running boosts lifespan by 12 years, finds new research (Runner's World)

Performance:

Latest Price: $81.187d-Return: 1.6%Market Cap: $8.3b

Big Movers:Miromatrix (MIRO): 218.27%Precision (DTIL): 37.93%Scholar Rock (SRRK): 36.36%

ABOUT SPANNR

We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.

If you have any questions about Spannr or want to get to know us better, 

contact us

 – we'd love to hear from you. We appreciate your interest in what we are creating.